Alzheimer's, ALS and cancer are diseases in which the new methodology Spatial Transcriptomics becomes an important tool. Joakim Lundeberg and Patrik Ståhl form KTH, have together with Jonas Frisén from Karolinska Institutet developed the methodology.
